Gene therapy in cancer;Terapia génica y cancer

Revista Medica de Chile

Volumn 126, Issue 4, 1998, Pages 439-449

  Arias P, Hugo ^a  

^a Instituto Nacional de Cancerología   (Colombia)

Author keywords

DNA, neoplasm; Gene therapy; Genetics, medical; Neoplasms

Indexed keywords

GENE THERAPY; GENE TRANSFER; HUMAN; NEOPLASM; REVIEW; TUMOR SUPPRESSOR GENE;

GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS;

EID: 3242841527     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. VOGELSTEIN B, KINZLER KW. The multistep nature of cancer. Trends Genet 1993; 9: 138-41.
2. WEINBERG RA. How cancer arises. Sci Am 1996; 275: 32-40.
3. MULLIGAN RC. The basis of gene therapy. Science 1993; 260: 926-32.
4. VILE R, RUSSELL SJ. Gene transfer technologies for the gene therapy of cancer. Gene Ther 1994; 1: 88-98.
5. JOLLY D. Viral vector systems for gene therapy. Cancer Gene Ther 1994; 1: 51-64.
6. GUNZBURG WH, SALMONS B. Development of retroviral vectors as safe, targeted gene delivery systems. J Mol Med 1996; 74: 171-82.
7. ROSS G, ERICKSON R, KNORR D, ET AL. 1996. Gene therapy in the United States: a five-year status report. Hum Gene Ther 1996; 7: 1781-90.
8. ROTH JA, CRISTIANO RJ. Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 1997; 89: 21-39.
9. TKECO DA, SELDEN RF. Non-viral gene therapy. Mol Med Today 1995; 1: 314-21.
10. DANKO I, WOLF JA. Direct gene transfer into muscle. Vaccine 1994; 12: 1499-502.
11. SVENSSON EC, TRIPATHY SK, LEIDEN JM. Muscle-based gene therapy: realistic possibilities for the future. Mol Med Today 1996; 2: 166-72.
12. WOLF JA, LUDTKE JJ, ACSADI G, ET AL. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992; 1: 363-9.
13. ROSENBERG SA, AEBERSOLD P, CORNETTA K, ET AL. Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 1990; 323: 570-8.
14. HWU P, YANNELLI J, KRIEGLER M, ET AL. Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans. J Immunol 1993; 150: 4104-15.
15. BRUYNS C, GERARD C, VeLU T. Cancer escape from immune surveillance: how can it be overcome by gene transfer? Eur J Cancer 1994; 30A: 1176-81.
16. BLANKESTEIN T. Increasing tumour immunogenicity by genetic modification. Eur J Cancer 1994; 30A: 1182-7.
17. PATERSON Y, IKONOMIDIS G. Recombinant Listeria monocytogenes cancer vaccines. Curr Opin Immunol 1996; 8: 664-9.
18. RESTIFO NP. The new vaccines: building viruses that elicit antitumor immunity. Curr Opin Immunol 1996; 8: 658-63.
19. GANSBACHER B, BANNERJI R, DANIELS B, ET AL. Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 1990; 50: 7820-5.
20. GASTL G, FINSTAD CL, GUARINI A, ET AL. Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res 1992; 52: 6229-36.
21. CORNETTA K, BEREBITSKY D, BEHNIA M, ET AL. A retroviral vector expressing human interferon g upregulates MHC antigen expression in human breast cancer and leukemia cell lines. Cancer Gene Ther 1994; 1: 91-8.
22. PLAKSIN D, GELBER C, FELDMAN M, EISENBACH L. Reversal of the metastasic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene. Proc Natl Acad Sci USA 1988; 85: 4463-7.
23. TANAKA K, GOrELIK E, WATANABE M, ET AL. Rejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene. Mol Cell Biol 1988; 8: 1857-61.
24. NABEL GJ, NABEL EG, YANG Z, ET AL. Direct gene transfer with DNA-liposome complexes in melanoma: expresion, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci (USA) 1993; 90: 11307-11.
25. CHEN L, ASHE S, BRADY WA, ET AL. Co-stimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71: 1093-102.
26. TOWNSEND SE, ALLISON JP. Tumor rejection after direct co-stimulation of CD8+ T cells by B7-transfected melanoma cells. Science 1993; 259: 308-70.
27. COLOMBO MP, GORNI G. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today 1994; 15: 48-51.
28. KLINGEMANN HG, DOUGHERTY GJ. Site-specific delivery of cytokines in cancer. Mol Med Today 1996; 2: 154-9.
29. ROBBINS P, KAWAKAMI Y. Human tumor antigens recognized by T cell. Curr Opin Immunol 1996; 8: 628-36.
30. COULIE PG. Human tumour antigens recognized by T cells: new perspectives for anticancer vaccines? Mol Med Today 1997; 3: 261-8.
31. RIGG A, SIKORA K. Genetic prodrug activation therapy. Mol Med Today 1997; 3: 359-66.
32. FREEMAN SM, ABBOUD CN, WHARTENBY KA, ET AL. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-83.
33. CULVER KW, RAM Z, WALLBRIGE S, ET AL. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-2.
34. WAGNER RW, FLANAGAN WM. Antisense technology and prospects for therapy of infectious disease and cancer. Mol Med Today 1997; 3: 31-8.
35. THOJAN J, JOHNSON TR, RUDIN SD, ET AL. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisease insulin-like growth factor I RNA. Science 1993; 259: 94-7.
36. MAZE R, HANENBERG H, WILLIAMS DA. Establishing chemoresistance in hematopoietic progenitor cells. Mol Med Today 1997; 3: 350-358.
37. SORRENTINO BP, BRANDT SJ, BODINE D, ET AL. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 1992; 257: 99-103.
38. KIRN DH, MCCORNICK F. Replicating viruses as selective cancer therapeutics. Mol Med Today 1996; 2: 519-27.
39. BRONTE V, TSUNG K, RAO JB, ET AL. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. J Immunol 1995; 154: 5282-92.
40. STEWART A. Bacterial vectors for cancer therapy. Mol Med Today 1997; 3: 141.